More Little Green Pharma Ltd. news
Little Green Pharma Ltd.ASX: LGP

$2.5m firm order increases expected DEMECAN revenue to $5.7m

May 26, 2021 at 11:37 PM EDT · Issued by Little Green Pharma Ltd.

Filed with ASX · May 26, 2021 at 11:37 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/dollar2.5m-firm-order-increases-expected-demecan-revenue-to-dollar5.7m

Little Green Pharma Ltd. on 6ix

Story so far

  • Firm purchase order from Demecan and acquisition of landMar 15, 2021
  • German Purchase Agreement with DemecanFeb 27, 2020

Earlier from Little Green Pharma

  • LGP agrees Danish Distribution Agreement with BalancialApr 19, 2021
  • Firm purchase order from Demecan and acquisition of landMar 14, 2021
  • Share Purchase Plan Offer BookletFeb 14, 2021
  • LGP secures firm commitments to raise $22 millionFeb 8, 2021
  • LGP exports first commercial shipment to GermanyFeb 5, 2021

Later from Little Green Pharma

  • Update to Sales and Distribution in Australia and GermanyJun 14, 2021
  • Exclusive distribution partner - leading Polish pharma groupJun 17, 2021
  • Investor Presentation - Denmark acquisition & capital raiseJun 22, 2021
  • LGP acquires Denmark facility and undertakes share placementJun 22, 2021
  • First Danish Shipment to Australia, Key AppointmentsSep 5, 2021
All Little Green Pharma news releases↗

Follow Little Green Pharma into a list and get an email when it puts out news.

Follow Little Green Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer